Transgenic Expression of the Amyloid-β Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease–Like Traits In Vivo

• Luca Giliberto ,

  * E-mail: lgiliberto@nshs.edu (LG); luciano.dadamio@einstein.yu.edu (LD)

  Affiliation The Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System (North Shore-LIJ), Manhasset, New York, United States of America

  ⨯
• Cristina d'Abramo,

  Affiliation The Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System (North Shore-LIJ), Manhasset, New York, United States of America

  ⨯
• Christopher Michael Acker,

  Affiliation Department of Pathology, Albert Einstein College of Medicine, New York, New York, United States of America

  ⨯
• Peter Davies,

  Affiliations The Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System (North Shore-LIJ), Manhasset, New York, United States of America, Department of Pathology, Albert Einstein College of Medicine, New York, New York, United States of America

  ⨯
• Luciano D'Adamio

  * E-mail: lgiliberto@nshs.edu (LG); luciano.dadamio@einstein.yu.edu (LD)

  Affiliation Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, United States of America

  ⨯